Success Metrics

Clinical Success Rate
74.5%

Based on 38 completed trials

Completion Rate
75%(38/51)
Active Trials
21(18%)
Results Posted
26%(10 trials)
Terminated
13(11%)

Phase Distribution

Ph phase_3
8
7%
Ph phase_2
1
1%
Ph phase_4
18
16%
Ph not_applicable
48
42%
Ph early_phase_1
1
1%

Phase Distribution

1

Early Stage

1

Mid Stage

26

Late Stage

Phase Distribution76 total trials
Early Phase 1First-in-human
1(1.3%)
Phase 2Efficacy & side effects
1(1.3%)
Phase 3Large-scale testing
8(10.5%)
Phase 4Post-market surveillance
18(23.7%)
N/ANon-phased studies
48(63.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

67.9%

38 of 56 finished

Non-Completion Rate

32.1%

18 ended early

Currently Active

21

trials recruiting

Total Trials

114

all time

Status Distribution
Active(34)
Completed(38)
Terminated(18)
Other(24)

Detailed Status

Completed38
unknown24
Recruiting15
Terminated13
Not yet recruiting10
Active, not recruiting6

Development Timeline

Analytics

Development Status

Total Trials
114
Active
21
Success Rate
74.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (1.3%)
Phase 21 (1.3%)
Phase 38 (10.5%)
Phase 418 (23.7%)
N/A48 (63.2%)

Trials by Status

unknown2421%
not_yet_recruiting109%
recruiting1513%
completed3833%
withdrawn54%
enrolling_by_invitation33%
terminated1311%
active_not_recruiting65%

Recent Activity

Clinical Trials (114)

Showing 20 of 114 trialsScroll for more
NCT05988411Not Applicable

ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients

Active Not Recruiting
NCT05511246Phase 2

Venous Ethanol for Ventricular Tachycardia

Recruiting
NCT04088071

Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

Recruiting
NCT07686328Not Applicable

A Multicenter Feasibility Study With the VERAFEYE Imaging and Guidance System as Anatomical Navigation System

Not Yet Recruiting
NCT07403760Not Applicable

Wellbeing and Survival Improvement With Event Reduction by Ablation for Atrial Fibrillation in the Very Elderly

Recruiting
NCT07316270Not Applicable

SAfety and eFfectiveness of cathetER Ablation for Atrial Fibrillation With Intracerebral Hemorrhage (SAFER-AF)

Recruiting
NCT07096219

Catheter Ablation for Functional Mitral Regurgitation in Persistent Atrial Fibrillation: Development and Validation of a Predictive Model-A Multicenter Prospective Cohort Study

Enrolling By Invitation
NCT07649603Not Applicable

Prophylactic Pulmonary Vein Isolation During Atrial Flutter Ablation

Not Yet Recruiting
NCT03347227Not Applicable

Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation

Active Not Recruiting
NCT07254455Not Applicable

CASTLE-HFpEF (Catheter Ablation for Atrial Fibrillation Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction)

Not Yet Recruiting
NCT06615596Early Phase 1

Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation

Recruiting
NCT02184013Not Applicable

Correlation of the Arrhythmia Mechanism and Substrate to Ablate Persistent Atrial Fibrillation Study

Active Not Recruiting
NCT02114528Phase 4

Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention

Terminated
NCT06505798Not Applicable

Cryoballoon/Radiofrequency/Pulsed Field Ablation of Atrial Fibrillation Versus Medical Treatment for Heart

Recruiting
NCT02627183

Circulating BDNF in Patients With Atrial Fibrillation Undergoing Catheter Ablation or Exercise Training

Completed
NCT05239364Not Applicable

Ablation of Consecutive Atrial Tachycardia

Recruiting
NCT05635864

Impact of Catheter Ablation on ABC Risk Scores

Completed
NCT07445334Not Applicable

Catheter Ablation Versus Anti-arrhythmic Drugs for Premature Ventricular Complexes

Not Yet Recruiting
NCT04239144Not Applicable

Sympathetic Denervation by Video-assisted Thoracoscopy in Control of Cardiac Arrhythmias in Patients With Chagas Disease

Completed
NCT05116384Not Applicable

Renal Denervation + PVI vs PVI Alone for Persistent AF

Recruiting

Drug Details

Intervention Type
DEVICE
Total Trials
114